Choksi Asia Ltd 530427.BO
₹160.00 ₹1.00 (0.62%) 1D
Last Updated: Jun 22, 12:00 AM·BSE
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
530427.BO Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: January 27, 2026
Report Source: 2026 2nd Quarter Report
Choksi Asia Ltd. Stock Analysis 530427.BO
India Health Care Nano Cap Report: Choksi Asia Ltd. engages in the manufacture and trade of photosensitized materials and other products for healthcare industry. The company is headquartered in Mumbai, Maharashtra and currently employs 9 full-time employees. The firm is engaged in the business of manufacturing x-ray films and trading in specialty x-ray films and medical equipment. The company is focused on the business of processing Jumbo Rolls of X-Ray films by slitting and cutting them into various sizes of X-Ray Films as per the requirements of the customers on a job-work basis. Its product categories include ultrasound and color doppler, x-ray film and chemicals, x-ray accessories and non-destructive testing (NDT). Its ultrasound and color doppler products include portable black and white, general imaging, cardiovascular and eSaote MyLab20 Family. Its x-ray film and chemicals include laser green, and laser chemical. The firm also offers radiation shielding materials, an x-ray generator, and radiography camera.
Read More Choksi Asia Ltd (530427.BO) Chart
Key Statistics of Choksi Asia Ltd (530427.BO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹161.00Volume
8389.00P/E Ratio (TTM)
26.3752 Week Range
Market Cap
765.43MAvg. Volume
5122.30Dividend Yield
-Financial Metrics & Statements of Choksi Asia Ltd (530427.BO)
FAQ's for Choksi Asia Ltd (530427.BO)
- According to Musaffa’s Shariah screening methodology, Choksi Asia Ltd (530427.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Choksi Asia Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Choksi Asia Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Choksi Asia Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Choksi Asia Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Choksi Asia Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.